This patent, along with a previous patent that is related to the processing of the aforementioned allogeneic tissue grafts, are associated with the Trinity Evolution and Trinity ELITE grafts. The Trinity grafts are cellular bone matrices that are processed by the Musculoskeletal Transplant Foundation and marketed for applications in orthopedic and spine surgery by Orthofix.
The Musculoskeletal Transplant Foundation, a nonprofit organization, is a national consortium of organ procurement organizations, tissue recovery organizations and academic medical institutions.
More articles on devices:
Zyga Technology taps into unmet needs with Glyder Facet Restoration Device study
Oxford Performance Materials gets $150k NIH grant to study implant-related infections
IlluminOss Medical receives FDA approval for Photodynamic Bone Stabilization System clinical trial
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
